• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Linical Co Ltd

+ Add to Watchlist

2183:JP

946.0 JPY 7.0 0.75%

As of 02:00:00 ET on 09/18/2014.

Snapshot for Linical Co Ltd (2183)

Open: 945.0 Day's Range: 940.0 - 947.0 Volume: 11,900
Previous Close: 939.0 52wk Range: 776.0 - 1,450.0 1-Yr Rtn: -24.07%

Stock Chart for 2183

No chart data available.
  • 2183:JP 946.0
  • 1D
  • 1M
  • 1Y
939.0
Interactive 2183 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2183

Current P/E Ratio (ttm) 24.2006
Estimated P/E(03/2015) 15.6687
Relative P/E vs. TPX 1.5172
Earnings Per Share (JPY) (ttm) 39.0900
Est. EPS (JPY) (03/2015) 60.3750
Est. PEG Ratio -
Market Cap (M JPY) 11,702.02
Shares Outstanding (M) 12.37
30 Day Average Volume 15,607
Price/Book (mrq) 6.1838
Price/Sale (ttm) 2.7571
Dividend Indicated Gross Yield 1.48%
Cash Dividend (JPY) 14.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 4.94%
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2183

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2183

LINICAL CO LTD is a Contract Research Organization (CRO) for Pharmaceutical Companies. The company specializes in Clinical Research Associate of Phase II and Phase III, while conducting other clinical trial related services such as Quality Management and Consulting.

Kazuhiro HatanoPresident/FounderKeigo TsujimotoExecutive Vice President
Akihiro TakahashiSenior Managing Director/CFOJun KawaiSenior Managing Director
More Company Profile & Key Executives for 2183

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil